This week we're adding a different twist to our typical episode, and we're diving into WHY Commodities can be accretive in your portfolio with Tim Pickering (@AuspiceTim). Tim is the Founder, President, and CIO of Auspice Capital Advisors and leads the strategic decision-making and the vision for Auspice's diverse suite of award-winning rules-based quantitative investment strategies.
In this week's episode, Tim illustrates why the current environment could be very bullish commodities long-term, active tactical strategies, and dives into Trend following, non-correlation, CTAs ability to act as a return-enhancer, inflation protection, and much more!
Chapters:
00:00-01:52 = Intro
01:53-09:48 = Born from Canadian Commodity Country
09:49-20:08= Shell Oil and Tactical Active Strategies
20:09-29:19 = The Auspice Edge vs Buy and Hold Commodities
29:20-40:28 = The other 25%, an Agnostic approach & the Adaptive Volatility process
40:29-57:03 = Crisis Alpha Opportunities, Inflation hedges & Institutional products
Follow along with Tim Pickering on Twitter @AuspiceTim and Auspice @AuspiceCapital. And for more information on Auspice check out their website and research!
Don't forget to subscribe to The Derivative, and follow us on Twitter at @rcmAlts and our host Jeff at @AttainCap2, or LinkedIn , and Facebook, and sign-up for our blog digest.
Disclaimer: This podcast is provided for informational purposes only and should not be relied upon as legal, business, or tax advice. All opinions expressed by podcast participants are solely their own opinions and do not necessarily reflect the opinions of RCM Alternatives, their affiliates, or companies featured. Due to industry regulations, participants on this podcast are instructed not to make specific trade recommendations, nor reference past or potential profits. And listeners are reminded that managed futures, commodity trading, and other alternative investments are complex and carry a risk of substantial losses. As such, they are not suitable for all investors. For more information, visit www.rcmalternatives.com/disclaimer
